285
Participants
Start Date
April 24, 2009
Primary Completion Date
May 30, 2012
Study Completion Date
July 7, 2016
Panitumumab
Panitumumab is a fully human immunoglobulin G (IgG)2 monoclonal antibody antagonist directed against human Epidermal Growth Factor receptor (EGFr).
Bevacizumab
Bevacizumab is a humanized monoclonal IgG1 antibody that is directed against Vascular Endothelial Growth Factor (VEGF).
mFOLFOX6
mFOLFOX6 regimen is a combination therapy of oxaliplatin (85 mg/m\^2) administered as a 2-hour infusion on Day 1; leucovorin (400 mg/m\^2) administered as a 2-hour infusion on Day 1; followed by a loading dose of 5-fluorouracil (5-FU; 400 mg/m\^2) IV bolus administered over approximately 2 to 4 minutes on Day 1, then 5- FU (2400 mg/m\^2) via ambulatory pump administered for a period of 46 to 48 hours.
Research Site, Edegem
Research Site, Charleroi
Research Site, Libramont
Research Site, Sint-Niklaas
Research Site, Staten Island
Research Site, East Setauket
Research Site, Alba (CN)
Research Site, Berlin
Research Site, Buffalo
Research Site, A Coruña
Research Site, Genova
Research Site, Hershey
Research Site, Philadelphia
Research Site, Bethesda
Research Site, Varese
Research Site, Baltimore
Research Site, Chesapeake
Research Site, Newport News
Research Site, Newport News
Research Site, Raleigh
Research Site, Huntersville
Research Site, San Sebastián de Los Reyes
Research Site, Málaga
Research Site, Mt. Pleasant
Research Site, Greenville
Research Site, Alpharetta
Research Site, Augusta
Research Site, Savannah
Research Site, Daytona Beach
Research Site, Hollywood
Research Site, Coral Springs
Research Site, Udine
Research Site, Boynton Beach
Research Site, Lake Worth
Research Site, Bielefeld
Research Site, Birmingham
Research Site, Huntsville
Research Site, Memphis
Research Site, Santander
Research Site, Magdeburg
Research Site, Danville
Research Site, Hazard
Research Site, Paducah
Research Site, Columbus
Research Site, Akron
Research Site, Mantova
Research Site, Indianapolis
Research Site, Lambertville
Research Site, Lansing
Research Site, Kalamazoo
Research Site, Gurnee
Research Site, Fano
Research Site, Peoria
Research Site, Overland Park
Research Site, Wichita
Research Site, Dallas
Research Site, Tyler
Research Site, Temple
Research Site, Corpus Christi
Research Site, Round Rock
Research Site, Austin
Research Site, Denver
Research Site, München
Research Site, München
Research Site, Post Falls
Research Site, Albuquerque
Research Site, Beverly Hills
Research Site, Burbank
Research Site, La Verne
Research Site, Riverside
Research Site, Fountain Valley
Research Site, Orange
Research Site, Regensburg
Research Site, Passau
Research Site, Berkeley
Research Site, Roseville
Research Site, Würzburg
Research Site, Vancouver
Research Site, Spokane
Research Site, Stamford
Research Site, Waterbury
Research Site, Boston
Research Site, Mountain Lakes
Research Site, Sparta
Research Site, White River Junction
Research Site, Calgary
Research Site, Edmonton
Research Site, Vancouver
Research Site, Victoria
Research Site, Oshawa
Research Site, Greenfield Park
Research Site, Montreal
Research Site, Québec
Research Site, Sabadell
Research Site, Elche
Lead Sponsor
Amgen
INDUSTRY